Aspira Pathlab & Diagnostics Ltd is in the business of pathology and related healthcare servicesBusiness Overview: Company is in the business of running, owning, managing and administering Diagnostics Centers in Mumbai
Aspira Pathlab & Diagnostics has dispatched letters to shareholders who have not registered their email addresses. These letters provide a web-link to access the company's Annual Report for the Financial Year 2025-26. The 53rd Annual General Meeting (AGM) is scheduled for Friday, September 25, 2026, at 02:00 P.M. (IST) and...
Aspira Pathlab & Diagnostics has announced its 53rd Annual General Meeting will be held virtually. Shareholders can attend via Video Conferencing or other audio-visual means to transact the business outlined in the AGM Notice. The company will facilitate electronic voting for members to cast their votes on resolutions. This virtual...
Aspira Pathlab & Diagnostics Limited has announced its 53rd Annual General Meeting. The meeting will be held on Friday, September 25, 2026, at 02:00 P.M. (IST) via Video Conferencing or Other Audio Visual Means, without physical presence. Shareholders will be able to transact business and vote electronically, both remotely and...
Aspira Pathlab & Diagnostics Limited announces its Internal Auditor, M/s. Vishal J Bhanushali and Associates, has resigned from their post. The firm cited preoccupation and other personal reasons for stepping down. This is a notable change in the company's internal oversight, which is vital for maintaining strong financial review and...
Aspira Pathlab & Diagnostics announced a key leadership change: Mr. Pankaj Jashwant Shah has resigned from his positions as Managing Director and Chief Executive Director. The company cited personal reasons for his departure, effective August 03, 2026. This executive transition impacts the company's top management structure, which is a significant...
